JP2017537888A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017537888A5 JP2017537888A5 JP2017522654A JP2017522654A JP2017537888A5 JP 2017537888 A5 JP2017537888 A5 JP 2017537888A5 JP 2017522654 A JP2017522654 A JP 2017522654A JP 2017522654 A JP2017522654 A JP 2017522654A JP 2017537888 A5 JP2017537888 A5 JP 2017537888A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- fusion protein
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/524,832 US10400029B2 (en) | 2011-06-28 | 2014-10-27 | Serpin fusion polypeptides and methods of use thereof |
| US14/524,832 | 2014-10-27 | ||
| PCT/US2015/057533 WO2016069574A1 (en) | 2014-10-27 | 2015-10-27 | Serpin fusion polypeptides and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020121953A Division JP2020180157A (ja) | 2014-10-27 | 2020-07-16 | セルピン融合ポリペプチド及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017537888A JP2017537888A (ja) | 2017-12-21 |
| JP2017537888A5 true JP2017537888A5 (enExample) | 2018-10-25 |
| JP6737781B2 JP6737781B2 (ja) | 2020-08-12 |
Family
ID=55858243
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017522654A Active JP6737781B2 (ja) | 2014-10-27 | 2015-10-27 | セルピン融合ポリペプチド及びその使用方法 |
| JP2020121953A Pending JP2020180157A (ja) | 2014-10-27 | 2020-07-16 | セルピン融合ポリペプチド及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020121953A Pending JP2020180157A (ja) | 2014-10-27 | 2020-07-16 | セルピン融合ポリペプチド及びその使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP3212290A4 (enExample) |
| JP (2) | JP6737781B2 (enExample) |
| KR (2) | KR20170091096A (enExample) |
| CN (2) | CN107206257A (enExample) |
| AU (3) | AU2015339507B2 (enExample) |
| BR (1) | BR112017008525A2 (enExample) |
| CA (1) | CA2965151A1 (enExample) |
| HK (1) | HK1244460A1 (enExample) |
| IL (2) | IL308589A (enExample) |
| MX (2) | MX2017005467A (enExample) |
| NZ (1) | NZ769391A (enExample) |
| RU (1) | RU2746550C2 (enExample) |
| SG (2) | SG11201703390SA (enExample) |
| UA (1) | UA127305C2 (enExample) |
| WO (1) | WO2016069574A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3117961A1 (en) * | 2018-10-29 | 2020-05-07 | Spin Therapeutics, Llc | Compositions and methods for alpha-1-antitrypsin disorders |
| CN111989340B (zh) * | 2018-11-18 | 2025-07-15 | 杭州博虎生物科技有限公司 | 一种重组人白细胞介素-10融合蛋白及其应用 |
| CN112315897A (zh) * | 2020-11-04 | 2021-02-05 | 深圳前海鹰岗生物科技有限公司 | 一种抑制细胞炎症反应释放治疗痛风急性发作的聚合物微针及制备方法 |
| WO2022133521A1 (en) * | 2020-12-21 | 2022-06-30 | Macquarie University | Treatment of glaucoma |
| GB202102258D0 (en) * | 2021-02-17 | 2021-03-31 | Arecor Ltd | Novel composition |
| EP4301333A2 (en) * | 2021-03-03 | 2024-01-10 | Formycon AG | Formulations of ace2 fc fusion proteins |
| CN113325181A (zh) * | 2021-04-25 | 2021-08-31 | 苏州市立医院(北区) | 丝氨酸蛋白酶抑制剂在用于脓毒症早期预警的标志物中的应用 |
| CN119638849A (zh) * | 2021-10-18 | 2025-03-18 | 深圳科兴药业有限公司 | 一种生长激素融合蛋白及其应用 |
| AU2023272089A1 (en) | 2022-05-16 | 2025-01-09 | Sanofi Aatd Inc. | Effective dosage of recombinant serpin-fc fusion protein for use in a method of treating aat deficiency in a subject |
| AU2024219542B1 (en) * | 2023-05-05 | 2024-10-03 | Ashley Maurice Buckle | Novel therapeutic polypeptide |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000052160A1 (en) * | 1999-03-01 | 2000-09-08 | Human Genome Sciences, Inc. | Human serpin proteins |
| US7317091B2 (en) * | 2002-03-01 | 2008-01-08 | Xencor, Inc. | Optimized Fc variants |
| US7217797B2 (en) * | 2002-10-15 | 2007-05-15 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| BRPI0412761A (pt) * | 2003-07-18 | 2006-09-26 | Vertex Pharma | inibidores de serino proteases, particularmente a protease ns3-ns4a do vhc |
| PL2520654T3 (pl) * | 2003-08-26 | 2017-08-31 | The Regents Of The University Of Colorado, A Body Corporate | Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych |
| BRPI0517837A (pt) * | 2004-11-12 | 2008-10-21 | Xencor Inc | variantes fc com ligação alterada a fcrn |
| US8802820B2 (en) * | 2004-11-12 | 2014-08-12 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| ES2336832T3 (es) * | 2005-07-22 | 2010-04-16 | Five Prime Therapeutics, Inc. | Composiciones y procedimientos para tratar enfermedades con proteinas de fusion de fgfr. |
| US7713521B2 (en) * | 2005-08-12 | 2010-05-11 | Schering Corporation | MCP1 fusions |
| AU2009262199B2 (en) * | 2008-06-27 | 2012-08-09 | Amgen Inc. | Ang-2 inhibition to treat multiple sclerosis |
| ES2733067T3 (es) * | 2008-12-19 | 2019-11-27 | Macrogenics Inc | Diacuerpos covalentes y usos de los mismos |
| CA2822366A1 (en) * | 2010-12-23 | 2012-06-28 | Janssen Biotech, Inc. | Active protease-resistant antibody fc mutants |
| ES2692268T5 (en) * | 2011-03-29 | 2025-02-26 | Roche Glycart Ag | Antibody fc variants |
| SG10201601621PA (en) * | 2011-06-28 | 2016-04-28 | Inhibrx Llc | Serpin fusion polypeptides and methods of use thereof |
| CN103946388A (zh) * | 2011-06-28 | 2014-07-23 | 英伊布里克斯有限责任公司 | Wap结构域融合多肽及其使用方法 |
| JP2015504675A (ja) * | 2012-01-10 | 2015-02-16 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ | アルファ−１アンチトリプシン融合分子の組成物、方法、及び使用 |
| HK1209034A1 (en) * | 2012-06-21 | 2016-03-24 | Indiana University Research And Technology Corporation | Incretin receptor ligand polypeptide fc-region fusion polypeptides and conjugates with altered fc-effector function |
| MX2014014804A (es) * | 2012-06-27 | 2015-02-12 | Hoffmann La Roche | Metodo para la elaboracion de conjugados de la region fc de anticuerpos que comprenden por lo menos una entidad de union que se une especificamente a un objetivo y usos del mismo. |
| HUE029634T2 (en) * | 2012-08-02 | 2017-03-28 | Hoffmann La Roche | A method for producing soluble FcR as an Fc fusion with an inert immunoglobulin Fc region and its uses |
| CA2893359C (en) * | 2012-12-05 | 2021-12-28 | Strategia Therapeutics, Inc. | Protein expression enhancing polypeptides |
-
2015
- 2015-10-27 WO PCT/US2015/057533 patent/WO2016069574A1/en not_active Ceased
- 2015-10-27 IL IL308589A patent/IL308589A/en unknown
- 2015-10-27 SG SG11201703390SA patent/SG11201703390SA/en unknown
- 2015-10-27 UA UAA201705128A patent/UA127305C2/uk unknown
- 2015-10-27 KR KR1020177014414A patent/KR20170091096A/ko not_active Ceased
- 2015-10-27 CN CN201580071331.7A patent/CN107206257A/zh active Pending
- 2015-10-27 IL IL251799A patent/IL251799B2/en unknown
- 2015-10-27 CN CN202111439584.9A patent/CN114316068A/zh active Pending
- 2015-10-27 NZ NZ769391A patent/NZ769391A/en unknown
- 2015-10-27 MX MX2017005467A patent/MX2017005467A/es unknown
- 2015-10-27 HK HK18103148.5A patent/HK1244460A1/zh unknown
- 2015-10-27 RU RU2017118325A patent/RU2746550C2/ru active
- 2015-10-27 SG SG10201903142RA patent/SG10201903142RA/en unknown
- 2015-10-27 AU AU2015339507A patent/AU2015339507B2/en active Active
- 2015-10-27 JP JP2017522654A patent/JP6737781B2/ja active Active
- 2015-10-27 BR BR112017008525-9A patent/BR112017008525A2/pt active Search and Examination
- 2015-10-27 KR KR1020237043666A patent/KR20240005109A/ko not_active Ceased
- 2015-10-27 EP EP15854670.5A patent/EP3212290A4/en active Pending
- 2015-10-27 CA CA2965151A patent/CA2965151A1/en active Pending
-
2017
- 2017-04-26 MX MX2021012047A patent/MX2021012047A/es unknown
-
2020
- 2020-07-16 JP JP2020121953A patent/JP2020180157A/ja active Pending
-
2021
- 2021-09-28 AU AU2021240153A patent/AU2021240153A1/en not_active Abandoned
-
2024
- 2024-05-29 AU AU2024203586A patent/AU2024203586A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024138397A5 (enExample) | ||
| RU2017118325A (ru) | Слитые серпиновые полипептиды и способы их применения | |
| NZ744257A (en) | Serpin fusion polypeptides and methods of use thereof | |
| JP6920230B2 (ja) | アルファ−１アンチトリプシン融合ポリペプチド、それをコードする核酸構築体、及びそれらの組成物 | |
| JP2022043042A5 (enExample) | ||
| JP6216921B2 (ja) | アルファ−１抗トリプシン融合分子のための組成物、方法および使用 | |
| JP2010524971A5 (enExample) | ||
| JP2018070625A5 (enExample) | ||
| CN113173995B (zh) | 一种结合冠状病毒的双特异性抗体 | |
| CN104114574B (zh) | 结合人补体c5的多肽 | |
| JP2023504914A5 (enExample) | ||
| JP2015504675A5 (enExample) | ||
| JP2012505902A5 (enExample) | ||
| JP2018537087A5 (enExample) | ||
| JP2014530611A5 (enExample) | ||
| CN103396479A (zh) | α-1-抗胰蛋白酶和载脂蛋白A-I的纯化方法 | |
| JP6938565B2 (ja) | Ｕｔｉ融合タンパク質 | |
| JP2008507298A5 (enExample) | ||
| JP2022509517A5 (enExample) | ||
| JP2007509984A5 (enExample) | ||
| JP2020019813A5 (enExample) | ||
| CN107226842B (zh) | 靶向pd-1的多肽及其应用 | |
| JP2022530742A5 (enExample) | ||
| JP2009507503A5 (enExample) | ||
| CN102690354A (zh) | 重组二聚化抗凝血酶III-Fc融合蛋白及其哺乳动物细胞高效表达系统 |